EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Surgical indications for hepatocellular adenoma: Diagnostic uncertainty and molecular risk stratification

Jingyu Tan, Ai Shen

Drug Discoveries & Therapeutics · 31.10.2026 · 20 (5) · 405-408

DOI: 10.5582/ddt.2026.01086 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Discoveries & Therapeutics, erschienen am 31.10.2026. Verfasst von Jingyu Tan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Health Examination and Oncology Screening Center, Chongqing University Cancer Hospital, Chongqing, China. Hauptthemen laut MEDLINE: Adenoma, Liver Cell, Liver Neoplasms. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenoma, Liver CellLiver NeoplasmsHumansRisk Assessment

Stichwörter der Autor:innen

clinical surveillancehemorrhage riskhepatobiliary surgerymalignant transformationmolecular pathology

Autor:innen und Institutionen

  • Health Examination and Oncology Screening Center, Chongqing University Cancer Hospital, Chongqing, China.
  • Hepatobiliary Pancreatic Cancer Center, Chongqing University Cancer Hospital, Chongqing, China.

Zitieren

APA

Tan, J., & Shen, A. (2026). Surgical indications for hepatocellular adenoma: Diagnostic uncertainty and molecular risk stratification. Drug Discoveries & Therapeutics, 20(5), 405-408. https://doi.org/10.5582/ddt.2026.01086

Vancouver

Tan J, Shen A. Surgical indications for hepatocellular adenoma: Diagnostic uncertainty and molecular risk stratification. Drug Discoveries & Therapeutics. 2026;20(5):405-408. doi:10.5582/ddt.2026.01086

BibTeX
@article{Tan2026,
  author = {Tan, Jingyu and Shen, Ai},
  title = {Surgical indications for hepatocellular adenoma: Diagnostic uncertainty and molecular risk stratification},
  journal = {Drug Discoveries & Therapeutics},
  year = {2026},
  volume = {20},
  number = {5},
  pages = {405--408},
  doi = {10.5582/ddt.2026.01086}
}
Kostenlos starten →